Last reviewed · How we verify
NCT05954585
Family Navigator Intervention
NA trial testing Treatment as usual in Treatment as Usual in 54 participants. Terminated before completion.
31 May 2024
Quick facts
| Lead sponsor | Rhode Island Hospital |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 54 |
| Start date | 2 December 2023 |
| Primary completion | 31 May 2024 |
| Estimated completion | 31 May 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Treatment as usual
- Family Navigator
Conditions studied
- Treatment as Usual — all drugs for Treatment as Usual →
- Family Navigator — all drugs for Family Navigator →
Sponsor
Rhode Island Hospital
Who can join
10 and older, any sex, with Treatment as Usual or Family Navigator. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will develop and examine the feasibility and acceptability of a family navigator protocol while leveraging digital health communication. It will employ an ecological model within a socio-cultural theoretic framework of mental health service disparities and barriers to treatment.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Development of an Emergency Department Family Navigator and Text Message Intervention for Caregivers to Reduce Youth Risk of Suicide and Self-injurious Behavior.
Cancilliere MK, Guthrie KM, Donise K, Lin T, et al · · 2024 · cited 2× · PMID 39058987
Verify or expand the search:
- PubMed search for NCT05954585
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Treatment as usual
Trials testing the same drug.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT04519008 — Effectiveness and Security Testing of a Mobile App · NA · not yet recruiting
- NCT06885047 — Culturally Centered CBT Protocol for Suicidal Behaviors Among Youth in Mexico City · NA · not yet recruiting
- NCT07033416 — A Trial Of Approach Bias Modification Training During Treatment For Cocaine Use Disorder · NA · recruiting
- NCT07331766 — Collaboratory Treatment Pathway for Chronic Pain Patients. · NA · enrolling by invitation
Other recruiting trials for Treatment as Usual
Currently open trials in the same condition.
- NCT07486037 — Caring for Caregivers · NA · recruiting
Other Rhode Island Hospital trials
Trials by the same sponsor.
- NCT06747221 — Implementation Science to Enhance HIV Testing Services During Emergency Care in Kenya · NA · not yet recruiting
- NCT07211087 — Improving the Treatment of Depression Among Youth With HIV · NA · not yet recruiting
- NCT06754527 — Options for Navigating Talking About Risk and Adolescent Choices · NA · not yet recruiting
- NCT07144631 — Peroneal Electrical Nerve Stimulation in Pregnancy for Restless Legs Syndrome · NA · recruiting
- NCT06942455 — A Sleep Hygiene Intervention to Improve Sleep Health in Urban, Latino Middle School Children · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05954585 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Rhode Island Hospital
- Last refreshed: 20 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05954585.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing